InvestorsHub Logo
Followers 21
Posts 1400
Boards Moderated 0
Alias Born 03/03/2021

Re: branster post# 462957

Wednesday, 04/27/2022 9:34:16 AM

Wednesday, April 27, 2022 9:34:16 AM

Post# of 695572
That was alphas point, 2016 article... Dr Lim and other said this..

the DCVax phase III program that is near completion, with high logistical complexity—it uses autologous tumor to stimulate autologous dendritic cells.



the 'near completion' in 2016 statement, will make some fearful and uncertain and have doubt on this companies ability to get this done.

2016 Current State of Immune-Based Therapies for Glioblastoma
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News